Published in J Neurol on June 01, 1987
A physical map of the human genome. Nature (2001) 12.39
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med (1995) 4.44
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET. J Cogn Neurosci (2000) 3.66
GLOBOSA: a homeotic gene which interacts with DEFICIENS in the control of Antirrhinum floral organogenesis. EMBO J (1992) 3.61
Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science (2001) 3.48
Spatial working memory in humans as revealed by PET. Nature (1993) 3.42
Dissociating verbal and spatial working memory using PET. Cereb Cortex (1996) 3.18
Verbal Working Memory Load Affects Regional Brain Activation as Measured by PET. J Cogn Neurosci (1997) 3.00
Inhibition in verbal working memory revealed by brain activation. Proc Natl Acad Sci U S A (1998) 3.00
Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol (1989) 2.93
The role of parietal cortex in verbal working memory. J Neurosci (1998) 2.89
Screening for depression: single question versus GDS. J Am Geriatr Soc (1994) 2.79
Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol (1993) 2.79
Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med (1994) 2.76
Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1) Science (1996) 2.73
Differentiation of normal and abnormal airway protection during swallowing using the penetration-aspiration scale. Dysphagia (1999) 2.44
Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry (1999) 2.38
Effectiveness of multiple EEGs in supporting the diagnosis of epilepsy: an operational curve. Epilepsia (1987) 2.31
Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med (1991) 2.18
Components of verbal working memory: evidence from neuroimaging. Proc Natl Acad Sci U S A (1998) 2.15
History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology (2009) 2.01
Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med (1993) 1.93
Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.89
Spatial versus Object Working Memory: PET Investigations. J Cogn Neurosci (1995) 1.88
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology (1999) 1.86
Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology (1991) 1.80
Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology (2010) 1.79
Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation (1990) 1.78
Age differences in behavior and PET activation reveal differences in interference resolution in verbal working memory. J Cogn Neurosci (2000) 1.76
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Ann Neurol (2000) 1.73
Sudden unexpected death of epileptic patient due to cardiac arrhythmia after seizure. Arch Neurol (1986) 1.56
Evidence for transhemispheric diaschisis in unilateral stroke. Arch Neurol (1989) 1.54
Correlation methods for the centering, rotation, and alignment of functional brain images. J Nucl Med (1990) 1.52
Advantages of short-lived positron-emitting radioisotopes for intracoronary radiation therapy with liquid-filled balloons to prevent restenosis. J Nucl Med (2001) 1.52
Glucose uptake by gliomas after treatment. A positron emission tomographic study. Arch Neurol (1989) 1.49
Sherpa brain glucose metabolism and defense adaptations against chronic hypoxia. J Appl Physiol (1985) (1996) 1.47
A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET. Neurology (1995) 1.47
An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. J Nucl Med (2001) 1.47
Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. J Clin Invest (1994) 1.46
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol (1996) 1.45
Comparison of human cerebral activation pattern during cutaneous warmth, heat pain, and deep cold pain. J Neurophysiol (1996) 1.42
Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation (2000) 1.42
Neuropsychological changes in olivopontocerebellar atrophy. Arch Neurol (1990) 1.42
Mutation rate of normal and malignant human lymphocytes. Cancer Res (1987) 1.42
Isolation of specific interference processing in the Stroop task: PET activation studies. Neuroimage (1997) 1.40
Role of the frontal lobes in the propagation of mesial temporal lobe seizures. Epilepsia (1992) 1.38
Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med (1993) 1.36
Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation (2001) 1.35
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol (1996) 1.35
Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology (2000) 1.33
The neural basis of task-switching in working memory: effects of performance and aging. Proc Natl Acad Sci U S A (2001) 1.30
Limbic activation and psychophysiologic responses to aversive visual stimuli. Interaction with cognitive task. Neuropsychopharmacology (2000) 1.28
Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcohol Clin Exp Res (1993) 1.27
"Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med (1993) 1.26
Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images. J Nucl Med (1994) 1.25
A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr. Appl Radiat Isot (2006) 1.24
A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum Mol Genet (1999) 1.24
Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli. J Neurophysiol (1994) 1.20
PET evidence for an amodal verbal working memory system. Neuroimage (1996) 1.19
The effect of emotional content on visual recognition memory: a PET activation study. Neuroimage (1998) 1.19
Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology (2003) 1.18
Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J Nucl Med (1996) 1.18
Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1998) 1.15
Stuttering following brain damage. Brain Lang (1978) 1.15
Response of the μ-opioid system to social rejection and acceptance. Mol Psychiatry (2013) 1.15
Imaging the vesicular monoamine transporter. Adv Neurol (2001) 1.15
Cerebellar and frontal hypometabolism in alcoholic cerebellar degeneration studied with positron emission tomography. Ann Neurol (1990) 1.15
Dose-dependence of 4-aminopyridine plasma concentrations and electrophysiological effects in dogs : potential relevance to ionic mechanisms in vivo. Circulation (2000) 1.12
In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate. Synapse (2010) 1.12
Benzodiazepine receptor increases after repeated seizures: evidence for localization to dentate granule cells. Proc Natl Acad Sci U S A (1982) 1.11
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. J Thromb Haemost (2012) 1.10
A crosslinguistic PET study of tone perception. J Cogn Neurosci (2000) 1.10
A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. Proc Natl Acad Sci U S A (1997) 1.10
Metabolic fate of [13N]ammonia in human and canine blood. J Nucl Med (1990) 1.09
Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse (2000) 1.09
The brain at high altitude: hypometabolism as a defense against chronic hypoxia? J Cereb Blood Flow Metab (1994) 1.09
Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biol Psychiatry (2001) 1.08
Performance comparison of parameter estimation techniques for the quantitation of local cerebral blood flow by dynamic positron computed tomography. J Cereb Blood Flow Metab (1985) 1.07
The kindling model of epilepsy: a review. Prog Neurobiol (1980) 1.07
REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology (2003) 1.06
Effects of nicotine on regional cerebral glucose metabolism in awake resting tobacco smokers. Neuroscience (2000) 1.06
Differences between lateral and mesial temporal metabolism interictally in epilepsy of mesial temporal origin. Neurology (1990) 1.06
The significance of oncogene amplification in primary breast cancer. Int J Cancer (1989) 1.06
18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer (1991) 1.06
Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. Biol Psychiatry (2001) 1.04
FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa. Neurology (1999) 1.04
Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography. J Urol (1991) 1.04
Decreased striatal monoaminergic terminals in Huntington disease. Neurology (2000) 1.03
Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA. Neurology (2003) 1.03
Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography. Ann Neurol (1999) 1.02
PET evidence for multiple strategies of categorization. Cogn Affect Behav Neurosci (2001) 1.02
Benzylidene derivatives of andrographolide inhibit growth of breast and colon cancer cells in vitro by inducing G(1) arrest and apoptosis. Br J Pharmacol (2008) 1.01
Functional heterogeneity of inferior frontal gyrus is shaped by linguistic experience. Brain Lang (2001) 1.00
Periodic maternal separation of neonatal rats produces region- and gender-specific effects on biogenic amine content in postmortem adult brain. Synapse (2001) 1.00
Proton computed tomography of human specimens. Phys Med Biol (1982) 1.00
The effect of graded aversive stimuli on limbic and visual activation. Neuropsychologia (2000) 1.00
Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol (1988) 1.00
Enhanced cardiac metabolism of plasma glucose in high-altitude natives: adaptation against chronic hypoxia. J Appl Physiol (1985) (1995) 0.99